Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Transcutaneous Carbon Dioxide Monitoring for the Prevention of Neonatal Morbidity and Mortality." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436660/all/Levonorgestrel_releasing_intrauterine_system_for_atypical_endometrial_hyperplasia:_Cochrane_systematic_review. Accessed 24 April 2024.
Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436660/all/Levonorgestrel_releasing_intrauterine_system_for_atypical_endometrial_hyperplasia:_Cochrane_systematic_review. Accessed April 24, 2024.
Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436660/all/Levonorgestrel_releasing_intrauterine_system_for_atypical_endometrial_hyperplasia:_Cochrane_systematic_review
Transcutaneous Carbon Dioxide Monitoring for the Prevention of Neonatal Morbidity and Mortality [Internet]. In: Cochrane Abstracts. [cited 2024 April 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436660/all/Levonorgestrel_releasing_intrauterine_system_for_atypical_endometrial_hyperplasia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality
ID - 436660
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436660/all/Levonorgestrel_releasing_intrauterine_system_for_atypical_endometrial_hyperplasia:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -